Design
Review
Key result
Cardiovascular disease is increasingly recognized as a consequence of maladaptive neuroimmune interactions, supporting the development of precision therapies targeting the neuroimmune axis.
Authors
Loading...
Neuroimmune axis may guide future trial design; leaves open whether targeted therapies will alter cardiovascular outcomes.
This review highlights the critical role of neuroimmune interactions in cardiovascular disease pathogenesis and proposes the neuroimmune axis as a novel therapeutic target.
Ma et al. (2026) conducted a review in Cardiovascular disease. Neuromodulatory strategies targeting the neuroimmune axis was evaluated. Cardiovascular disease is increasingly recognized as a consequence of maladaptive neuroimmune interactions, supporting the development of precision therapies targeting the neuroimmune axis.